Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients

The order directs federal agencies to implement most-favored-nation prescription drug pricing for American consumers. The Secretary of Commerce and the United States Trade Representative are instructed to prevent foreign countries from engaging in practices that force American patients to subsidize global pharmaceutical research and development. The Secretary of Health and Human Services is tasked to facilitate programs for direct-to-consumer sales at the most-favored-nation price and to set price targets in line with those in comparably developed nations. If significant progress is not made, the Secretary is authorized to propose rulemaking to impose most-favored-nation pricing and consider allowing importation of prescription drugs from developed nations with low-cost prescription drugs.